Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Malic dehydrogenase

(Synonyms: MDH, Malate Dehydrogenase, EC 1.1.1.37) Copy Product Info
🥰Excellent

Synonyms: MDH, Malate Dehydrogenase, EC 1.1.1.37

Catalog No. T76118 Copy Product Info
🥰Excellent
Malic dehydrogenase catalyzes the reversible conversion of oxaloacetate and malate and is closely associated with the oxidation and reduction of dinucleotide coenzymes. Malic dehydrogenase serves as a fundamental enzyme in cellular metabolism and is widely utilized in research involving energy metabolism, mitochondrial function, redox homeostasis, and enzymatic reaction networks.

Malic dehydrogenase

Cas No. 9001-64-3
Pack SizePriceUSA StockGlobal StockQuantity
5 mgInquiryInquiryInquiry
50 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Malic dehydrogenase catalyzes the reversible conversion of oxaloacetate and malate and is closely associated with the oxidation and reduction of dinucleotide coenzymes. Malic dehydrogenase serves as a fundamental enzyme in cellular metabolism and is widely utilized in research involving energy metabolism, mitochondrial function, redox homeostasis, and enzymatic reaction networks.
In vitro
Method: Partially purified pig-heart mitochondrial malic dehydrogenase was studied at 25°C in Tris-acetate buffer of ionic strength 0.05 at pH 8.0. Initial-rate and product-inhibition experiments compared oxaloacetate with the alternative substrate ketomalonate; kinetic constants were extrapolated to zero-order conditions for substrate and coenzyme.
Rresult: With oxaloacetate versus ketomalonate, maximum initial velocity was 6.3±0.5×10⁴ versus 2.6±0.2×10⁴ min⁻¹; the DPN dissociation constant was 4.9±0.3×10⁻⁴ versus 2.2±0.1×10⁻⁴ M; the DPNH dissociation constant was 3.9±1.0×10⁻⁶ versus 2.4±0.2×10⁻⁶ M; and the DPNH Michaelis constant was 1.4±0.2×10⁻⁵ versus 1.2±0.2×10⁻⁵ M. The proportional reductions in velocity and DPN dissociation supported a reciprocating compulsory-order mechanism involving interacting enzyme subunits.[1]
Method: L-(−)-Malate was determined enzymatically using malic dehydrogenase and diphosphopyridine nucleotide. An alkaline medium was used to bind generated protons, and oxaloacetate was trapped as its hydrazone to shift the equilibrium toward malate oxidation. DPNH formation was monitored spectrophotometrically. The recommended MDH preparation had a specific activity of at least 2,000 units/mg according to the Bücher definition or 36 units/mg according to the Racker definition; contamination with lactate dehydrogenase or glycerol-1-phosphate dehydrogenase was required to be below 0.05% of MDH activity.
Rresult: Relatively high concentrations of DPN and malic dehydrogenase, together with oxaloacetate trapping, enabled quantitative and sufficiently rapid oxidation of L-(−)-malate for spectrophotometric determination. [2]
SynonymsMDH, Malate Dehydrogenase, EC 1.1.1.37
Chemical Properties
Cas No.9001-64-3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 80 mg/mL, Sonication is recommended.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
µL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: Malic dehydrogenase in vitro